Search Results for "levobunolol"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for levobunolol. Results 1 to 8 of 8 total matches.

Metipranolol: A New Beta-blocker For Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Oct 05, 1990  (Issue 828)
twice 5 ml − $14.06 0.5% solution 1 drop twice 10 ml − 25.63 Levobunolol — Betagan (Allergan) 0.25 ...
Metipranolol hydrocholride 0.3% (OptiPranolol - Bausch & Lomb), a nonselective beta-adrenergic receptor blocking drug, was recently marketed of ophthalmic use to decrease intraolular pressure in ocular hypertension or chronic open-angle glaucoma. Beta-blockers available in the USA for treatment of glaucoma are listed in this article.
Med Lett Drugs Ther. 1990 Oct 5;32(828):91-2 |  Show IntroductionHide Introduction

A Topical Prostaglandin for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Nov 08, 1996  (Issue 987)
b.i.d. 41.26 0.5% 41.26 Levobunolol − Betagan (Allergan) 0.25% 1 drop b.i.d. 32.62 0.5% 1 drop once ...
Lantaoprost, a prostaglandin F2-alpha analog, has been approved by the FDA for topical treatment of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension refractory to other drugs.
Med Lett Drugs Ther. 1996 Nov 8;38(987):100-1 |  Show IntroductionHide Introduction

A Topical Carbonic Anhydrase Inhibitor For Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Sep 01, 1995  (Issue 956)
Cost* Beta-blockers Betaxolol − Betoptic (Alcon) 0.25% 1 drop b.i.d. $ 38.76 0.5% 38.76 Levobunolol ...
Dorzolamide hydrochloride (Trusopt - Merck), a thienothio-pyran-2-sulfonamide carbonic anhydrase inhibitor, was recently approved by the US Food and Drug Administration in a 2% ophthalmic solution for treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Med Lett Drugs Ther. 1995 Sep 1;37(956):76-7 |  Show IntroductionHide Introduction

Brimonidine - An Alpha2-Agonist for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Jun 06, 1997  (Issue 1002)
drop b.i.d. 34.28 Levobunolol − average generic price 0.5% 1 drop once 16.29 Betagan (Allergan) 0.5 ...
Brimonidine tartrate 0.2% ophthalmic solution (Alphagan - Allergan), a selective alpha2-adrenergic agonist, has been approved by the US Food and Drug Administration (FDA) for treatment of increased intraocular pressure due to open-angle glaucoma or ocular hypertension and for its prevention in patients undergoing argon laser trabeculoplasty.
Med Lett Drugs Ther. 1997 Jun 6;39(1002):54-5 |  Show IntroductionHide Introduction

Brinzolamide/Brimonidine (Simbrinza) for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Jul 22, 2013  (Issue 1421)
Levobunolol – Betagan (Allergan) 0.5% soln* 5, 10, 15 mL 1 drop qAM or bid 40.00 generic 0.25%, 0.5% soln* 5 ...
The FDA has approved Simbrinza (Alcon), an ophthalmic combination of the carbonic anhydrase inhibitor brinzolamide and the selective alpha2-adrenergic receptor agonist brimonidine, for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. Simbrinza is the first product to combine drugs from these 2 classes.
Med Lett Drugs Ther. 2013 Jul 22;55(1421):57-8 |  Show IntroductionHide Introduction

Two New Drugs for Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Jul 16, 2018  (Issue 1551)
1 drop qAM or bid 13.00 Levobunolol – generic 0.5% soln* 5, 10, 15 mL 1 drop qAM or bid 10.003 ...
The FDA has approved two new ophthalmic drugs for reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension: latanoprostene bunod (Vyzulta – Bausch and Lomb), a modified prostaglandin analog, and netarsudil (VRhopressa – Aerie), the first Rho kinase inhibitor to be approved in the US.
Med Lett Drugs Ther. 2018 Jul 16;60(1551):117-20 |  Show IntroductionHide Introduction

Drugs for Open-Angle Glaucoma

   
The Medical Letter on Drugs and Therapeutics • Apr 28, 2025  (Issue 1727)
– generic 1% soln* 5, 10, 15 mL 1 drop qAM or bid 13.00 Levobunolol – generic 0.5% soln* 5 mL 1 drop qAM ...
Glaucoma is a progressive optic neuropathy associated with increased intraocular pressure (IOP; normal range 8-22 mm Hg), which is the only disease-related factor that can be modified. Topical drugs that lower IOP are the first line of treatment for open-angle glaucoma.
Med Lett Drugs Ther. 2025 Apr 28;67(1727):65-8   doi:10.58347/tml.2025.1727a |  Show IntroductionHide Introduction

Drugs for Common Eye Disorders

   
The Medical Letter on Drugs and Therapeutics • Dec 02, 2019  (Issue 1586)
% soln* 5, 10, 15 mL 1 drop qAM or bid 13.00 Levobunolol – generic 0.5% soln* 5, 10, 15 mL 1 drop qAM ...
This issue includes reviews of drugs for glaucoma, age-related macular degeneration (AMD), bacterial conjunctivitis, and dry eye disease. Allergic conjunctivitis is reviewed in a separate issue.
Med Lett Drugs Ther. 2019 Dec 2;61(1586):187-94 |  Show IntroductionHide Introduction